Trane Technologies insider plans sale of 137 shares

Trane Technologies insider sale notice: An insider, Elizabeth Elwell, filed to sell 137 shares of Trane Technologies common stock, with an aggregate market value of 63096.72, through UBS Financial Services on the NYSE around February 10, 2026.

Rhea-AI Filing Summary

Trane Technologies insider sale notice: An insider, Elizabeth Elwell, filed to sell 137 shares of Trane Technologies common stock, with an aggregate market value of 63096.72, through UBS Financial Services on the NYSE around February 10, 2026.

The shares to be sold come from recent restricted stock unit (RSU) acquisitions, including 76 shares acquired on February 7, 2026 and 61 shares acquired on February 6, 2026 from the issuer. The filing also notes a prior sale of 46 common shares on February 6, 2026 for gross proceeds of 20752.13. Trane Technologies had 221,331,905 common shares outstanding when this notice was prepared.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale is disclosed for Trane Technologies (TT) in this notice?

The notice shows insider Elizabeth Elwell plans to sell 137 Trane Technologies common shares, with an aggregate market value of 63096.72, through UBS Financial Services on the NYSE around February 10, 2026. This is a planned sale, not yet executed at the time of filing.

How were the Trane Technologies (TT) shares being sold originally acquired?

The 137 Trane Technologies shares come from recent restricted stock unit (RSU) grants. The insider acquired 76 common shares on February 7, 2026 and 61 common shares on February 6, 2026 from the issuer, according to the acquisition and payment details in the notice.

What prior Trane Technologies (TT) stock sales has the insider made recently?

The filing reports that Elizabeth Elwell previously sold 46 Trane Technologies common shares on February 6, 2026, generating gross proceeds of 20752.13. This prior transaction is disclosed as part of required reporting of all issuer securities sold by the insider during the past three months.

How many Trane Technologies (TT) shares were outstanding when this sale notice was filed?

At the time the notice was prepared, Trane Technologies had 221,331,905 common shares outstanding. This figure provides context for the planned 137-share sale by insider Elizabeth Elwell and reflects the company’s total common stock base referenced in the disclosure.

Which broker and exchange are involved in the Trane Technologies (TT) insider sale?

The planned sale of 137 Trane Technologies common shares will be handled by UBS Financial Services, Inc., based at 11 Madison Ave in New York. The filing states that the shares are expected to be sold on the NYSE around February 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002011933
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Trane Technologies plc
SEC File Number	001-34400
Address of Issuer	170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, CO. DUBLIN IRELAND 00000
Phone	732-652-7000
Name of Person for Whose Account the Securities are To Be Sold	Elwell Elizabeth A.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	137	63096.72	221331905	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/07/2026	RSU	Issuer			76	02/07/2026	NA
Common	02/06/2026	RSU	Issuer			61	02/06/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Elizabeth Elwell 170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, CO. DUBLIN L2 00000	Common	02/06/2026	46	20752.13

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Elizabeth Elwell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)